Cofoe Medical Technology Co., Ltd. has fixed the offer price for its Hong Kong H-share listing at HK$39.33 per share, exclusive of standard levies and brokerage fees.

According to the prospectus, final details on subscription levels for both the International Offering and the Hong Kong Public Offering, as well as the allocation results, are scheduled for release on 5 May 2026. Subject to the Global Offering becoming unconditional by 8:00 a.m. that day, trading in Cofoe Medical’s H Shares is expected to commence on the Main Board of the Stock Exchange of Hong Kong at 9:00 a.m. on 6 May 2026. Shares will trade in board lots of 100.

The company has appointed Mr Zhang Min as Executive Director and Chairman, with three additional executive directors and three independent non-executive directors on the board.